[HTML][HTML] Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research

BM Leon, TM Maddox - World journal of diabetes, 2015 - ncbi.nlm.nih.gov
The incidence of diabetes mellitus (DM) continues to rise and has quickly become one of the
most prevalent and costly chronic diseases worldwide. A close link exists between DM and …

[HTML][HTML] GH and the cardiovascular system: an update on a topic at heart

J Isgaard, M Arcopinto, K Karason, A Cittadini - Endocrine, 2015 - Springer
In this review, the importance of growth hormone (GH) for the maintenance of normal cardiac
function in adult life is discussed. Physiological effects of GH and underlying mechanisms for …

The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

J Ren, P Anversa - Biochemical pharmacology, 2015 - Elsevier
Metabolic syndrome is a cluster of risk factors including obesity, dyslipidemia, hypertension,
and insulin resistance. A number of theories have been speculated for the pathogenesis of …

[HTML][HTML] Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes

P Fabbi, P Spallarossa, S Garibaldi, C Barisione… - PLoS …, 2015 - journals.plos.org
Background Insulin-like growth factor-1 (IGF-1) promotes the survival of cardiomyocytes by
activating type 1 IGF receptor (IGF-1R). Within the myocardium, IGF-1 action is modulated by …

[HTML][HTML] Effects of lactic acid bacteria on cardiac apoptosis are mediated by activation of the phosphatidylinositol-3 kinase/AKT survival-signalling pathway in rats fed a …

HF Wang, PP Lin, CH Chen… - International …, 2015 - spandidos-publications.com
Through a high-fat diet, obesity leads to cardiomyocyte dysfunction and apoptosis. In
addition, there is no evidence that probiotics have potential health effects associated with …

Myostatin and insulin-like growth factor-1 in hypertensive heart disease: a prospective study in human heart donors

J Fernandez-Sola, F Borrisser-Pairo… - Journal of …, 2015 - journals.lww.com
Objective: The physiopathological mechanisms implicated in hypertensive heart disease are
multi-factorial, including myocyte hypertrophy, apoptosis and myocardial remodelling. In this …

The pathological role of adipose tissue aging in the progression of systemic insulin resistance

Y Yoshida, I Shimizu, T Minamino - Inflammation and Regeneration, 2015 - jstage.jst.go.jp
** Correspondence should be addressed to: Tohru Minamino, MD, Ph. D., Department of
Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and …

The multiple actions of the insulin-like growth factor-I signaling in the myocardium

A Philippou, M Maridaki, T Karatzas… - Introduction to …, 2015 - Springer
The insulin-like growth factor-I (IGF-I) is an important growth factor which regulates a variety
of cellular responses and has important roles in multiple biological systems. IGF-I is …

[PDF][PDF] Elucidation of mechanisms involved in Arsenic Trioxide induced cardiotoxicity and its possible amelioration with phloretin

VP Vineetha - 2015 - ir.niist.res.in
Arsenic trioxide (ATO) is among the first-line chemotherapeutic drugs used in oncological
practice. It has shown substantial efficacy in treating patients with relapsed or refractory …

Early Growth Response protein 1 (Egr-1) expression by Insulin-like growth factor 1 (IGF-1) involves MAPKs and PKB pathways

V Youreva - 2015 - papyrus.bib.umontreal.ca
Aberrant vascular remodelling underlies the pathogenesis of major cardiovascular diseases
(CVD), such as atherosclerosis and hypertension. Abnormal growth, migration and …